Use of thromboelastography to assess the combined role of pregnancy and obesity on coagulation: a prospective study

被引:25
作者
Sharma, S. [1 ]
Uprichard, J. [2 ]
Moretti, A. [1 ]
Boyce, H. [1 ]
Szydlo, R. [2 ]
Stocks, G. [1 ]
机构
[1] Queen Charlottes & Chelsea Hosp, Dept Anaesthesia, London W6 0XG, England
[2] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Haematol, London, England
关键词
Thromboelastography; Obstetric; Pregnancy; Body mass index; Coagulation; Thrombosis; Thromboprophylaxis; VENOUS THROMBOEMBOLISM; SONOCLOT ANALYSIS; POSTPARTUM;
D O I
10.1016/j.ijoa.2012.12.004
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Thromboelastography (TEG (R)) is a point of care monitor of whole blood coagulation and has previously demonstrated hypercoagulability in both pregnant and obese populations. However, the individual and combined contribution of pregnancy and obesity on coagulation status has not been defined. We carried out a study to assess the effect of both pregnancy and body mass index (BMI) on blood coagulation using laboratory tests of coagulation and thromboelastography. Methods: This was a prospective study of 96 women divided into four equal groups; non-pregnant lean (NPL) BMI <25 kg/m(2), pregnant lean (PL) BMI <25 kg/m(2), non-pregnant obese (NPO) BMI >35 kg/m(2) and pregnant obese (PO) BMI >35 kg/m(2). Women were of either >36 weeks of gestation presenting for elective caesarean delivery; non-pregnant women with BMI >35 kg/m(2) presenting for bariatric surgery; or non-pregnant volunteers with BMI <25 kg/m(2). Eligible women were then allocated to a group based on BMI and pregnancy status. TEG (R) analysis, full blood count and coagulation profiles were performed on all patients. The main outcome measures were TEG (R) profile (including r time, k time, alpha angle, maximum amplitude and coagulation index), platelet count, activated partial thromboplastin time, prothrombin time, and fibrinogen levels. Results: The coagulation index was significantly higher in the obese patient groups compared with the lean groups (NPL -4.5 vs. NPO 1.9, P < 0.001; PL -4.3 vs. PO 2.5, P < 0.001). However, comparisons between the pregnant and non-pregnant groups when matched for BMI demonstrated no significant difference in coagulation. Conclusions: The combined effect of pregnancy and obesity on coagulation has not previously been investigated. Thromboelastographic comparison of pregnant and non-pregnant females separated into low or high BMI cohorts in the current study suggests that obesity correlates more with a hypercoagulable state than with pregnancy, particularly in pregnant patients at the extremes of low and high body weight. Crown Copyright (C) 2012 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 19 条
[1]   Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry [J].
Armstrong, S. ;
Fernando, R. ;
Ashpole, K. ;
Simons, R. ;
Columb, M. .
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2011, 20 (04) :293-298
[2]  
Centre for Maternal and Child Enquiries (CMACE), 2011, 8 CMACE
[3]   Coagulation and fibrinolysis abnormalities in obesity [J].
De Pergola, G ;
Pannacciulli, N .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (10) :899-904
[4]   Is it time to invest in a thromboelastograph? [J].
Gorton, H ;
Lyons, G .
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 1999, 8 (03) :171-178
[5]   Thromboelastography identifies sex-related differences in coagulation [J].
Gorton, HJ ;
Warren, ER ;
Simpson, NAB ;
Lyons, GR ;
Columb, MO .
ANESTHESIA AND ANALGESIA, 2000, 91 (05) :1279-1281
[6]   Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study [J].
Heit, JA ;
Kobbervig, CE ;
James, AH ;
Petterson, TM ;
Bailey, KR ;
Melton, LJ .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (10) :697-706
[7]   Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients - A subgroup analysis of the PREVENT Trial [J].
Kucher, N ;
Leizorovicz, A ;
Vaitkus, PT ;
Cohen, AT ;
Turpie, AGG ;
Olsson, CG ;
Goldhaber, SZ .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (03) :341-345
[8]   Elaboration of type-1 plasminogen activator inhibitor from adipocytes - A potential pathogenetic link between obesity and cardiovascular disease [J].
Lundgren, CH ;
Brown, SL ;
Nordt, TK ;
Sobel, BE ;
Fujii, S .
CIRCULATION, 1996, 93 (01) :106-110
[9]   Current Concepts: Venous Thromboembolic Disease and Pregnancy [J].
Marik, Paul E. ;
Plante, Lauren A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19) :2025-2033
[10]   Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction [J].
McCrath, DJ ;
Cerboni, E ;
Frumento, RJ ;
Hirsh, AL ;
Bennett-Guerrero, E .
ANESTHESIA AND ANALGESIA, 2005, 100 (06) :1576-1583